1. World Health Organization, Coronavirus disease 2019 (COVID-19): situation report — 36 (available at https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200225-sitrep-36-covid-19.pdf).
2. Clinical Characteristics of Coronavirus Disease 2019 in China
3. H. Li , S. Wang , F. Zhong , W. Bao , Y. Li , L. Liu , H. Wang , Y. He , Age-dependent risks of Incidence and Mortality of COVID-19 in Hubei Province and Other Parts of China. medRxiv, 10.1101/2020.02.25.20027672 (2020).
4. N. Ferguson , D. Laydon , G. Nedjati-Gilani , N. Imai , K. Ainslie , M. Baguelin , S. Bhatia , A. Boonyasiri , Z. Cucunubá, G. Cuomo-Dannenburg , A. Dighe , I. Dorigatti , H. Fu , K. Gaythorpe , W. Green , A. Hamlet , W. Hinsley , L. Okell , S. van Elsland , H. Thompson , R. Verity , E. Volz , H. Wang , Y. Wang , P. Walker , C. Walters , P. Winskill , C. Whittaker , C. Donnelly , S. Riley , A. Ghani , Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. online report (available at https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-COVID19-NPI-modelling-16-03-2020.pdf). (2020).
5. The epidemiology of the outbreak of severe acute respiratory syndrome (SARS) in Hong Kong – what we do know and what we don't